US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

1.790
-0.030-1.65%

Trading Nov 26 12:57 ET

47.48MMarket Cap-1672P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-53.18%-6.08M

-14.64%-5.76M

14.96%-3.59M

-28.41%-18.87M

-44.97%-5.66M

-20.60%-3.97M

0.59%-5.02M

-72.32%-4.22M

-18.81%-14.69M

5.83%-3.9M

Net income from continuing operations

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

Depreciation and amortization

5.53%21.64K

1.75%20.59K

6.68%20.53K

30.25%83.58K

30.25%23.59K

15.04%20.51K

1.09%20.24K

134.40%19.24K

314.41%64.17K

212.89%18.11K

Other non cash items

74.18%-44.18K

-462.31%-166.13K

-63.74%-200.15K

-85.24%-383.19K

3.74%-135.7K

-377.36%-171.11K

--45.85K

---122.24K

-506.01%-206.86K

-1,892.18%-140.97K

Change In working capital

-37,071.39%-1.93M

-23.37%1.05M

-8.89%416.81K

-70.81%442.23K

-512.96%-1.38M

-100.56%-5.18K

624.31%1.37M

-10.39%457.47K

559.35%1.51M

124.14%334.02K

-Change in receivables

----

-3,682.15%-130.07K

----

105.73%3.63K

----

-Change in prepaid assets

-121.74%-39.33K

-202.43%-403.3K

45.70%-298.47K

249.17%174.39K

-44.40%149.37K

-62.52%180.92K

13.36%393.74K

54.79%-549.64K

76.64%-116.91K

148.60%268.66K

-Change in payables and accrued expense

-3,920.98%-1.85M

318.79%1.48M

-33.47%703.59K

-160.29%-643.16K

-109.23%-976.79K

-115.34%-46.1K

-32.87%-677.85K

-39.33%1.06M

304.59%1.07M

73.71%-466.85K

-Change in other current liabilities

----

-107.11%-50.53K

----

6.85%711.07K

----

-Change in other working capital

76.81%-32.47K

-101.84%-30.43K

123.14%11.68K

829.45%1.09M

-1,131.70%-371.34K

-3,266.10%-140K

1,781.46%1.65M

-196.73%-50.47K

-266.22%-149.65K

30.07%-30.15K

Cash from discontinued investing activities

Operating cash flow

-53.18%-6.08M

-14.64%-5.76M

14.96%-3.59M

-28.41%-18.87M

-44.97%-5.66M

-20.60%-3.97M

0.59%-5.02M

-72.32%-4.22M

-18.81%-14.69M

5.83%-3.9M

Investing cash flow

Cash flow from continuing investing activities

-100.00%-1

-34.25%2M

43.27%3.02M

169.19%10.22M

2,247.65%3.14M

17,002.33%1.93M

120.45%3.05M

27,026.26%2.11M

-15,582.52%-14.77M

1,305.89%133.83K

Net PPE purchase and sale

99.85%-1

-491.30%-21.55K

--0

87.09%-15.36K

99.80%-19

98.86%-650

91.82%-3.64K

-41.15%-11.05K

-26.26%-118.95K

15.32%-9.4K

Net investment purchase and sale

--0

-33.62%2.02M

42.53%3.02M

169.86%10.24M

2,093.62%3.14M

4,115.55%1.93M

120.54%3.05M

--2.12M

---14.66M

--143.23K

Cash from discontinued investing activities

Investing cash flow

-100.00%-1

-34.25%2M

43.27%3.02M

169.19%10.22M

2,247.65%3.14M

17,002.33%1.93M

120.45%3.05M

27,026.26%2.11M

-15,582.52%-14.77M

1,305.89%133.83K

Financing cash flow

Cash flow from continuing financing activities

501.37%808.68K

356.75%10.04M

-119.47%-145.8K

16,147.61%12.64M

44,398.94%9.56M

753.38%134.47K

161,115.26%2.2M

2,072.16%748.91K

-100.19%-78.77K

-121.69%-21.58K

Net issuance payments of debt

-2.15%-23.12K

0.61%-22.11K

-5.83%-22.87K

-13.07%-89.07K

-4.62%-22.58K

-9.96%-22.63K

-1,732.13%-22.25K

43.09%-21.61K

-258.86%-78.77K

1.68%-21.58K

Net common stock issuance

429.46%831.79K

352.55%10.04M

--0

--12.73M

--9.58M

--157.1K

--2.22M

--770.52K

--0

Proceeds from stock option exercised by employees

--1

--13.58K

--157.94K

----

--0

----

Net other financing activities

--0

---280.87K

----

Cash from discontinued financing activities

Financing cash flow

501.37%808.68K

356.75%10.04M

-119.47%-145.8K

16,147.61%12.64M

44,398.94%9.56M

753.38%134.47K

161,115.26%2.2M

2,072.16%748.91K

-100.19%-78.77K

-121.69%-21.58K

Net cash flow

Beginning cash position

167.14%16.97M

77.31%10.67M

61.10%11.83M

-80.11%7.34M

-60.55%4.3M

-55.69%6.35M

-82.49%6.02M

-80.11%7.34M

391.88%36.91M

-73.40%10.91M

Current changes in cash

-176.73%-5.27M

2,741.25%6.28M

47.59%-713.64K

113.53%4M

285.69%7.04M

42.68%-1.9M

101.11%221.11K

45.39%-1.36M

-200.81%-29.55M

8.99%-3.79M

Effect of exchange rate changes

364.77%382.81K

-88.21%13.12K

-1,251.69%-442.5K

2,152.38%488.4K

113.78%483.25K

-36.43%-144.58K

217.72%111.31K

177.91%38.42K

-123.61%-23.8K

250.42%226.05K

End cash Position

180.77%12.08M

167.14%16.97M

77.31%10.67M

61.10%11.83M

-60.55%4.3M

-55.69%6.35M

-82.49%6.02M

-80.11%7.34M

Free cash flow

-53.15%-6.08M

-14.98%-5.78M

15.18%-3.59M

-27.48%-18.88M

-44.62%-5.66M

-18.56%-3.97M

1.39%-5.03M

-72.22%-4.23M

-18.87%-14.81M

5.86%-3.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-53.18%-6.08M	-14.64%-5.76M	14.96%-3.59M	-28.41%-18.87M	-44.97%-5.66M	-20.60%-3.97M	0.59%-5.02M	-72.32%-4.22M	-18.81%-14.69M	5.83%-3.9M
Net income from continuing operations	4.93%-4.49M	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M
Depreciation and amortization	5.53%21.64K	1.75%20.59K	6.68%20.53K	30.25%83.58K	30.25%23.59K	15.04%20.51K	1.09%20.24K	134.40%19.24K	314.41%64.17K	212.89%18.11K
Other non cash items	74.18%-44.18K	-462.31%-166.13K	-63.74%-200.15K	-85.24%-383.19K	3.74%-135.7K	-377.36%-171.11K	--45.85K	---122.24K	-506.01%-206.86K	-1,892.18%-140.97K
Change In working capital	-37,071.39%-1.93M	-23.37%1.05M	-8.89%416.81K	-70.81%442.23K	-512.96%-1.38M	-100.56%-5.18K	624.31%1.37M	-10.39%457.47K	559.35%1.51M	124.14%334.02K
-Change in receivables	----	----	----	-3,682.15%-130.07K	----	----	----	----	105.73%3.63K	----
-Change in prepaid assets	-121.74%-39.33K	-202.43%-403.3K	45.70%-298.47K	249.17%174.39K	-44.40%149.37K	-62.52%180.92K	13.36%393.74K	54.79%-549.64K	76.64%-116.91K	148.60%268.66K
-Change in payables and accrued expense	-3,920.98%-1.85M	318.79%1.48M	-33.47%703.59K	-160.29%-643.16K	-109.23%-976.79K	-115.34%-46.1K	-32.87%-677.85K	-39.33%1.06M	304.59%1.07M	73.71%-466.85K
-Change in other current liabilities	----	----	----	-107.11%-50.53K	----	----	----	----	6.85%711.07K	----
-Change in other working capital	76.81%-32.47K	-101.84%-30.43K	123.14%11.68K	829.45%1.09M	-1,131.70%-371.34K	-3,266.10%-140K	1,781.46%1.65M	-196.73%-50.47K	-266.22%-149.65K	30.07%-30.15K
Cash from discontinued investing activities
Operating cash flow	-53.18%-6.08M	-14.64%-5.76M	14.96%-3.59M	-28.41%-18.87M	-44.97%-5.66M	-20.60%-3.97M	0.59%-5.02M	-72.32%-4.22M	-18.81%-14.69M	5.83%-3.9M
Investing cash flow
Cash flow from continuing investing activities	-100.00%-1	-34.25%2M	43.27%3.02M	169.19%10.22M	2,247.65%3.14M	17,002.33%1.93M	120.45%3.05M	27,026.26%2.11M	-15,582.52%-14.77M	1,305.89%133.83K
Net PPE purchase and sale	99.85%-1	-491.30%-21.55K	--0	87.09%-15.36K	99.80%-19	98.86%-650	91.82%-3.64K	-41.15%-11.05K	-26.26%-118.95K	15.32%-9.4K
Net investment purchase and sale	--0	-33.62%2.02M	42.53%3.02M	169.86%10.24M	2,093.62%3.14M	4,115.55%1.93M	120.54%3.05M	--2.12M	---14.66M	--143.23K
Cash from discontinued investing activities
Investing cash flow	-100.00%-1	-34.25%2M	43.27%3.02M	169.19%10.22M	2,247.65%3.14M	17,002.33%1.93M	120.45%3.05M	27,026.26%2.11M	-15,582.52%-14.77M	1,305.89%133.83K
Financing cash flow
Cash flow from continuing financing activities	501.37%808.68K	356.75%10.04M	-119.47%-145.8K	16,147.61%12.64M	44,398.94%9.56M	753.38%134.47K	161,115.26%2.2M	2,072.16%748.91K	-100.19%-78.77K	-121.69%-21.58K
Net issuance payments of debt	-2.15%-23.12K	0.61%-22.11K	-5.83%-22.87K	-13.07%-89.07K	-4.62%-22.58K	-9.96%-22.63K	-1,732.13%-22.25K	43.09%-21.61K	-258.86%-78.77K	1.68%-21.58K
Net common stock issuance	429.46%831.79K	352.55%10.04M	--0	--12.73M	--9.58M	--157.1K	--2.22M	--770.52K	--0	--0
Proceeds from stock option exercised by employees	--1	--13.58K	--157.94K	----	----	--0	--0	--0	----	----
Net other financing activities	--0	--0	---280.87K	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	501.37%808.68K	356.75%10.04M	-119.47%-145.8K	16,147.61%12.64M	44,398.94%9.56M	753.38%134.47K	161,115.26%2.2M	2,072.16%748.91K	-100.19%-78.77K	-121.69%-21.58K
Net cash flow
Beginning cash position	167.14%16.97M	77.31%10.67M	61.10%11.83M	-80.11%7.34M	-60.55%4.3M	-55.69%6.35M	-82.49%6.02M	-80.11%7.34M	391.88%36.91M	-73.40%10.91M
Current changes in cash	-176.73%-5.27M	2,741.25%6.28M	47.59%-713.64K	113.53%4M	285.69%7.04M	42.68%-1.9M	101.11%221.11K	45.39%-1.36M	-200.81%-29.55M	8.99%-3.79M
Effect of exchange rate changes	364.77%382.81K	-88.21%13.12K	-1,251.69%-442.5K	2,152.38%488.4K	113.78%483.25K	-36.43%-144.58K	217.72%111.31K	177.91%38.42K	-123.61%-23.8K	250.42%226.05K
End cash Position	180.77%12.08M	167.14%16.97M	77.31%10.67M	61.10%11.83M	61.10%11.83M	-60.55%4.3M	-55.69%6.35M	-82.49%6.02M	-80.11%7.34M	-80.11%7.34M
Free cash flow	-53.15%-6.08M	-14.98%-5.78M	15.18%-3.59M	-27.48%-18.88M	-44.62%-5.66M	-18.56%-3.97M	1.39%-5.03M	-72.22%-4.23M	-18.87%-14.81M	5.86%-3.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data